Compugen (CGEN) Accumulated Depreciation & Amortization (2011 - 2025)
Compugen recorded quarterly Accumulated Depreciation & Amortization of $4000.0 in Q4 2025, up 100.0% quarter-over-quarter from $2000.0 in Q4 2024, and up 100.0% year-over-year from $2000.0 in Q4 2024.
Compugen's Accumulated Depreciation & Amortization history runs 8 years deep, the most recent figure standing at $4000.0 for Q4 2025.
- In Q4 2025, Accumulated Depreciation & Amortization rose 100.0% year-over-year to $4000.0; the TTM figure through Dec 2025 stood at $4000.0 (up 100.0% YoY), while the FY2025 annual figure was $4000.0, up 100.0% from the prior year.
- Accumulated Depreciation & Amortization came in at $4000.0 for Q4 2025 at Compugen, up from $2000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $6.2 million in Q4 2022 to a low of $2000.0 in Q4 2024.
- A 4-year average of $3.0 million and a median of $2.9 million in 2021 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization advanced 6.62% in 2022 and soared 100.0% in 2025, its largest moves.
- Compugen's Accumulated Depreciation & Amortization stood at $5.8 million in 2021, then gained by 6.62% to $6.2 million in 2022, then tumbled by 99.97% to $2000.0 in 2024, then jumped by 100.0% to $4000.0 in 2025.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $4000.0, $2000.0, and $6.2 million for Q4 2025, Q4 2024, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2022 | 6.23 Mn |
| Dec 31, 2022 | 6.23 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Dec 31, 2020 | 5.41 Mn |
| Dec 31, 2020 | 5.41 Mn |
| Dec 31, 2013 | 8.82 Mn |
| Dec 31, 2013 | 8.82 Mn |
| Dec 31, 2012 | 8.45 Mn |
| Dec 31, 2012 | 8.45 Mn |
| Dec 31, 2011 | 8.15 Mn |
| Dec 31, 2011 | 8.15 Mn |